Application of Pulsed Rhythmic Drug Administration to Ovulation Induction Therapy in PCOS Patients with Clomiphene-Resistance: a Retrospective Research
- PMID: 34085207
- PMCID: PMC8526461
- DOI: 10.1007/s43032-021-00639-7
Application of Pulsed Rhythmic Drug Administration to Ovulation Induction Therapy in PCOS Patients with Clomiphene-Resistance: a Retrospective Research
Abstract
There is currently a dispute over the choice of ovulation induction treatment for infertile women with polycystic ovary syndrome (PCOS). The objective of this study is to compare the therapeutic effect of pulsed rhythmic administration protocol (PRAP) with conventional letrozole + human menopausal gonadotropin (HMG) in patients with clomiphene-resistance polycystic ovary syndrome (PCOS). A retrospective analysis of 821 intrauterine insemination (IUI) cycles between January 2015 and January 2020 was performed. Of these, 483 cycles were treated with a pulsed rhythmic administration protocol (PRAP), and 338 cycles were treated with conventional letrozole + HMG protocol (LHP). The therapeutic effect of the two protocols has been compared. The pregnancy rate was 18.07% in the LHP and 27.07% in the PRAP. The ongoing pregnancy rate in LHP was 14.46% and in PRAP was 22.73%. The research suggests that PRAP is more effective than LHP and could be an adequate ovulation induction strategy for the IUI cycle of patients with clomiphene-resistance PCOS.
Keywords: Intrauterine insemination; Polycystic ovary syndrome; Pulsed rhythmic administration.
© 2021. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study.Drug Des Devel Ther. 2015 Nov 11;9:6001-8. doi: 10.2147/DDDT.S83259. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26648691 Free PMC article. Clinical Trial.
-
Ovulation induction and intrauterine insemination in infertile women with polycystic ovary syndrome: A comparison of drugs.Eur J Obstet Gynecol Reprod Biol. 2018 Dec;231:117-121. doi: 10.1016/j.ejogrb.2018.08.002. Epub 2018 Aug 3. Eur J Obstet Gynecol Reprod Biol. 2018. PMID: 30366343
-
A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome.Fertil Steril. 2019 Mar;111(3):571-578.e1. doi: 10.1016/j.fertnstert.2018.11.030. Epub 2019 Jan 22. Fertil Steril. 2019. PMID: 30683591 Clinical Trial.
-
Effects of letrozole alone or in combination with gonadotropins on ovulation induction and clinical pregnancy in women with polycystic ovarian syndrome: a systematic review and meta-analysis of randomized controlled trials.Hormones (Athens). 2024 Sep;23(3):497-508. doi: 10.1007/s42000-024-00531-4. Epub 2024 Jan 27. Hormones (Athens). 2024. PMID: 38280115
-
Is combined letrozole and clomiphene superior to either as monotherapy: a systemic review and meta-analysis based on clinical trials.Gynecol Endocrinol. 2024 Dec;40(1):2405114. doi: 10.1080/09513590.2024.2405114. Epub 2024 Sep 19. Gynecol Endocrinol. 2024. PMID: 39297798
References
-
- Zhang Y, Ho K, Keaton JM, Hartzel DN, Day F, Justice AE, Josyula NS, Pendergrass SA, Actkins K'E, Davis LK, Velez Edwards DR, Holohan B, Ramirez A, Stanaway IB, Crosslin DR, Jarvik GP, Sleiman P, Hakonarson H, Williams MS, Lee MTM. A genome-wide association study of polycystic ovary syndrome identified from electronic health records. American journal of obstetrics and gynecology. 2020;223:559.e1–559.e21. doi: 10.1016/j.ajog.2020.04.004. - DOI - PubMed
-
- Teede HJ, Misso ML, Boyle JA, Garad RM, McAllister V, Downes L, Gibson M, Hart RJ, Rombauts L, Moran L, Dokras A, Laven J, Piltonen T, Rodgers RJ, Thondan M, Costello MF, Norman RJ, International PCOS Network Translation and implementation of the Australian-led PCOS guideline: clinical summary and translation resources from the International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. The Medical journal of Australia. 2018;209(S7):S3–s8. doi: 10.5694/mja18.00656. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical